世界の非ホジキンリンパ腫治療薬市場は、2021年に約83億3,000万米ドルと評価され、予測期間の2022年から2029年には約8.50%の健全な成長率で成長すると予測されています。
非ホジキンリンパ腫（NHL）は、人体内で異常なリンパ球が生成される疾患です。このリンパ球は死滅せず、治療しない限り体内で増殖と分裂を繰り返します。NHLは一般的にリンパ節に発生しますが、治療が間に合わなければリンパ系全体に広がる可能性があります。非ホジキンリンパ腫治療薬市場は、タイプ、治療タイプ、投与経路、流通チャネル、エンドユーザーに基づいて細分化されます。業界の市場成長は、これらのセグメントの成長から検査され、ユーザーが市場の洞察を概観し、コア市場アプリケーションを分類するための決定を下すのに役立ちます.
非ホジキンリンパ腫のイベントの増加は市場の成長につながり、いくつかのタイプのNHLも含むほぼすべてのタイプの癌の有病率が高い傾向が見られます。 非ホジキンリンパ腫では、難治性・増悪した患者の治療が重要な原動力となっています。多くのタイプの非ホジキンリンパ腫に対する効率的な治療薬の開発における研究開発活動の継続と増加が、主要な推進要因の1つです。また、市場関係者による投資の増加も、長期的な成長の要因となっています。また、経口薬の需要の高まりも市場成長に寄与しており、ほとんどの製品がカプセルや錠剤の形で提供されています。
新興国で承認された治療薬のコストが上昇すると、高度な治療薬の採用が抑制されます。 非ホジキンリンパ腫治療薬市場の成長は、免疫療法などの特定の種類の治療に起因する高コストの影響を受けています。この病気の治療方法の知識を知らない訓練を受けた専門家が不足していると、予測期間中の世界の非ホジキンリンパ腫市場の成長が抑制される可能性があります。
また、国民の健康意識の高まりも、市場の成長を大きく後押ししています。米国がん協会によると、非ホジキンリンパ腫は約80,470人と推定されています。最も高い発生率は、女性では80〜84歳、男性では85〜89歳の間の年齢層であると思われます。患者を効果的に治療するために、より良い臨床の必要性がますます高まっており、市場の成長を牽引しています。
非ホジキンリンパ腫治療薬の世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。非ホジキンリンパ腫のような血液がんを含むあらゆる種類のがんの有病率と認知度が高いため、北アメリカが市場を支配しています。このため、非ホジキンリンパ腫の治療には、免疫療法などの高価な治療法が採用されています。アジア太平洋地域は、予測期間中に最も急速に成長する市場です。アジア太平洋地域の日本は、強力な人口基盤を持つKYMRIAHなどの高価な治療薬を承認しており、アジア太平洋市場の成長に大きく貢献しています。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Non-Hodgkin lymphoma treatment Market, by Region, 2019-2029 (USD Billion)
1.2.2. Non-Hodgkin lymphoma treatment Market, by Therapy, 2019-2029 (USD Billion)
1.2.3. Non-Hodgkin lymphoma treatment Market, by Disease, 2019-2029 (USD Billion)
1.2.4. Non-Hodgkin lymphoma treatment Market, by Distribution, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Non-Hodgkin lymphoma treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Non-Hodgkin lymphoma treatment Market Dynamics
3.1. Non-Hodgkin lymphoma treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing investments by Market players
3.1.1.2. Rising Demand for oral drugs
3.1.2. Market Challenges
3.1.2.1. High Cost of Non-Hodgkin lymphoma treatment
3.1.3. Market Opportunities
3.1.3.1. Increase in Non-Hodgkin Lymphoma
3.1.3.2. Rising Healthcare Awareness
Chapter 4. Global Non-Hodgkin lymphoma treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Non-Hodgkin lymphoma treatment Market, by Therapy
6.1. Market Snapshot
6.2. Global Non-Hodgkin lymphoma treatment Market by Therapy, Performance - Potential Analysis
6.3. Global Non-Hodgkin lymphoma treatment Market Estimates & Forecasts by Therapy 2019-2029 (USD Billion)
6.4. Non-Hodgkin lymphoma treatment Market, Sub Segment Analysis
6.4.1. Chemotherapy
6.4.2. Targeted Therapy
6.4.3. Immunotherapy
6.4.4. Others
Chapter 7. Global Non-Hodgkin lymphoma treatment Market, by Disease type
7.1. Market Snapshot
7.2. Global Non-Hodgkin lymphoma treatment Market by Disease type, Performance - Potential Analysis
7.3. Global Non-Hodgkin lymphoma treatment Market Estimates & Forecasts by Disease type 2019-2029 (USD Billion)
7.4. Non-Hodgkin lymphoma treatment Market, Sub Segment Analysis
7.4.1. B-Cell Lymphoma
7.4.2. T-cell Lymphoma
Chapter 8. Global Non-Hodgkin lymphoma treatment Market, by Distribution channel
8.1. Market Snapshot
8.2. Global Non-Hodgkin lymphoma treatment Market by Distribution channel, Performance - Potential Analysis
8.3. Global Non-Hodgkin lymphoma treatment Market Estimates & Forecasts by Distribution channel 2019-2029 (USD Billion)
8.4. Non-Hodgkin lymphoma treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail pharmacies
8.4.3. Others
Chapter 9. Global Non-Hodgkin lymphoma treatment Market, Regional Analysis
9.1. Non-Hodgkin lymphoma treatment Market, Regional Market Snapshot
9.2. North America Non-Hodgkin lymphoma treatment Market
9.2.1. U.S. Non-Hodgkin lymphoma treatment Market
9.2.1.1. Therapy breakdown estimates & forecasts, 2019-2029
9.2.1.2. Disease type breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Non-Hodgkin lymphoma treatment Market
9.3. Europe Non-Hodgkin lymphoma treatment Market Snapshot
9.3.1. U.K. Non-Hodgkin lymphoma treatment Market
9.3.2. Germany Non-Hodgkin lymphoma treatment Market
9.3.3. France Non-Hodgkin lymphoma treatment Market
9.3.4. Spain Non-Hodgkin lymphoma treatment Market
9.3.5. Italy Non-Hodgkin lymphoma treatment Market
9.3.6. Rest of Europe Non-Hodgkin lymphoma treatment Market
9.4. Asia-Pacific Non-Hodgkin lymphoma treatment Market Snapshot
9.4.1. China Non-Hodgkin lymphoma treatment Market
9.4.2. India Non-Hodgkin lymphoma treatment Market
9.4.3. Japan Non-Hodgkin lymphoma treatment Market
9.4.4. Australia Non-Hodgkin lymphoma treatment Market
9.4.5. South Korea Non-Hodgkin lymphoma treatment Market
9.4.6. Rest of Asia Pacific Non-Hodgkin lymphoma treatment Market
9.5. Latin America Non-Hodgkin lymphoma treatment Market Snapshot
9.5.1. Brazil Non-Hodgkin lymphoma treatment Market
9.5.2. Mexico Non-Hodgkin lymphoma treatment Market
9.6. Rest of The World Non-Hodgkin lymphoma treatment Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Takeda Pharmaceutical Company Limited
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. AstraZeneca plc
10.2.3. Bayer AG
10.2.4. Novartis AG
10.2.5. Kyowa Kirin Co. Ltd.
10.2.6. Bristol Myers Squibb Company
10.2.7. Janssen Pharmaceuticals Inc.
10.2.8. Merck & Co. Inc.
10.2.9. Sanofi India
10.2.10. AbbVie. Inc
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
List of Tables
TABLE 1. Global Non-Hodgkin lymphoma treatment Market, report scope
TABLE 2. Global Non-Hodgkin lymphoma treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Non-Hodgkin lymphoma treatment Market estimates & forecasts by Therapy 2019-2029 (USD Billion)
TABLE 4. Global Non-Hodgkin lymphoma treatment Market estimates & forecasts by Disease type 2019-2029 (USD Billion)
TABLE 5. Global Non-Hodgkin lymphoma treatment Market estimates & forecasts by Distribution channel 2019-2029 (USD Billion)
TABLE 6. Global Non-Hodgkin lymphoma treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Non-Hodgkin lymphoma treatment Market by Region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Non-Hodgkin lymphoma treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Non-Hodgkin lymphoma treatment Market by Region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Non-Hodgkin lymphoma treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Non-Hodgkin lymphoma treatment Market by Region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Non-Hodgkin lymphoma treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Non-Hodgkin lymphoma treatment Market by Region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Non-Hodgkin lymphoma treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Non-Hodgkin lymphoma treatment Market by Region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Non-Hodgkin lymphoma treatment Market
TABLE 71. List of primary sources, used in the study of global Non-Hodgkin lymphoma treatment Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Non-Hodgkin lymphoma treatment Market, research methodology
FIG 2. Global Non-Hodgkin lymphoma treatment Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Non-Hodgkin lymphoma treatment Market, key trends 2021
FIG 5. Global Non-Hodgkin lymphoma treatment Market, growth prospects 2022-2029
FIG 6. Global Non-Hodgkin lymphoma treatment Market, porters 5 force model
FIG 7. Global Non-Hodgkin lymphoma treatment Market, pest analysis
FIG 8. Global Non-Hodgkin lymphoma treatment Market, value chain analysis
FIG 9. Global Non-Hodgkin lymphoma treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Non-Hodgkin lymphoma treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Non-Hodgkin lymphoma treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Non-Hodgkin lymphoma treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Non-Hodgkin lymphoma treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Non-Hodgkin lymphoma treatment Market, Regional snapshot 2019 & 2029
FIG 15. North America Non-Hodgkin lymphoma treatment Market 2019 & 2029 (USD Billion)
FIG 16. Europe Non-Hodgkin lymphoma treatment Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Non-Hodgkin lymphoma treatment Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Non-Hodgkin lymphoma treatment Market 2019 & 2029 (USD Billion)
FIG 19. Global Non-Hodgkin lymphoma treatment Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
